{
  "trial_id": "NCT02700776",
  "overall_assessment": "likely_ineligible",
  "inclusion": [
    {
      "criterion": "Female greater than or equal to 40 years",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "Presenting to UM Breast Center and BWMC for breast imaging: screening or diagnostic",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "mammogram, breast ultrasound (US), breast MRI, stereotactic core needle biopsy",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "ultrasound core needle biopsy, MRI guided breast biopsy",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Patients with a recent screening diagnosis of breast cancer < = 3months",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "Patients presenting with mammogram findings with BIRADS of 0-6 < =3 months",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Able to understand and the willingness to sign a written informed consent document",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Patients with a personal history of stage 0-4 breast cancer >3months",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Patients who have known severe and/or uncontrolled medical or psychiatric conditions",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "or other conditions that could affect their participation in the study, or personal history of other malignancies",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "Patients who are unfit or unable to comply with having breast imaging studies such as mammogram, ultrasound, and MRI or breast biopsy or with study procedures-blood draw",
      "label": "triggers",
      "evidence": "none"
    },
    {
      "criterion": "Patients with personal history of ovarian cancer or other cancers",
      "label": "unknown",
      "evidence": "unknown"
    },
    {
      "criterion": "Patients with a personal history of breast biopsy positive for atypical ductal hyperplasia (ADH), atypical lobular hyperplasia (ALH), lobular carcinoma in situ (LCIS)",
      "label": "triggers",
      "evidence": "none"
    }
  ],
  "notes": "Patient is an obese, mentally retarded girl with Turner syndrome. She has been treating with GH since 6 months ago without estrogen therapy to avoid menarche and reach the ideal height.",
  "_meta": {
    "topic_id": "49",
    "trial_id": "NCT02700776",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}